Document:

Exhibit
10.2

 

THE
WARRANT EVIDENCED HEREBY, AND THE SECURITIES ISSUABLE HEREUNDER, HAVE BEEN AND SHALL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “ACT”) OR THE APPLICABLE STATE SECURITIES LAWS. THE WARRANT AND SUCH SECURITIES HAVE
BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND SHALL NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED,
OTHER THAN IN ACCORDANCE WITH SECTION 13, UNLESS THE PROPOSED DISPOSITION IS THE SUBJECT OF A CURRENTLY EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE
REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT AND SUCH STATE SECURITIES
LAWS IN CONNECTION WITH SUCH DISPOSITION.

 

THIS
WARRANT, AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT, ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND OTHER PROVISIONS SET
FORTH IN THIS WARRANT.

 

SANARA
MEDTECH INC.

COMMON
STOCK WARRANT

 

Original
Issue Date: April 4, 2022

 

Void
After: 5 PM Eastern Time on August 10, 2030

 

This
Warrant Is Issued to

Furneaux
Capital Holdco, LLC (DBA BlueIO)

 

(hereinafter
called the “Holder,” which term shall include the Holder’s legal representatives, heirs, successors and permitted
assigns) by Sanara MedTech Inc., a Texas corporation (hereinafter referred to as the “Company”).

 

The
Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions
set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the
Expiration Date (as defined below), 12,301 duly authorized, validly issued, fully paid, nonassessable shares of the Company’s Common
Stock, par value $0.001 per share (the “Common Stock”), at an initial purchase price per share equal to $12.05 per
share. The number of shares of Common Stock and the purchase price thereof shall be adjusted or readjusted from time to time as provided
in this Warrant (as so adjusted, the “Warrant Shares” and the “Exercise Price”, respectively).

 

“Expiration
Date” means 5 PM Eastern Time on August 10, 2030.

 

    	1

     

    

 

	1.	Exercise
    of Warrant. The Holder may exercise this Warrant, in whole or in part (except as to a fractional share), during the period beginning
    on the Original Issue Date and ending on the Expiration Date, by (i) delivering a subscription agreement, in the form attached hereto
    as Exhibit A (the “Subscription Form”), duly executed by the Holder, specifying the number of Warrant Shares
    to be issued to the Holder as a result of such exercise, (ii) surrendering this Warrant to the Company, properly endorsed by the
    Holder (or if this Warrant has been destroyed, stolen or has otherwise been misplaced, by delivering to the Company an affidavit
    of loss duly executed by the Holder), and (iii) tendering payment for the shares of Common Stock designated by the Exercise Notice
    in lawful money of the United States in the form of cash, bank or certified check made payable to the order of the Company, or by
    wire transfer of immediately available funds, or by the cancellation of indebtedness of the Company owed to the Holder, or in any
    combination thereof, of the applicable Exercise Price as to which this Warrant is being exercised.
	 	 
	2.	Net
    Exchange.

 

	 	a.	Generally.
    The Holder may, in lieu of exercising this Warrant pursuant to the terms of Section 1, elect to exchange this Warrant at any time
    prior to the Expiration Date by delivering to the Company a written notice, in the form attached hereto as Exhibit B (the
    “Exchange Notice”), duly executed by the Holder, specifying the number of Warrant Shares to be issued to the Holder
    as a result of such exchange. The Holder shall thereupon be entitled to receive the number of Warrant Shares equal to the product
    of (i) the number of Warrant Shares issuable upon exercise of this Warrant (or, if only a portion of this Warrant is being exercised,
    issuable upon the exercise of such portion) for cash, and (ii) a fraction, the numerator of which is the Fair Market Value (as defined
    below) per share of Common Stock at the time of such exercise minus the Exercise Price in effect at the time of such exercise,
    and the denominator of which is the Fair Market Value per share of Common Stock at the time of such exercise, such number of shares
    so issuable upon such exchange to be rounded down to the nearest whole number of shares of Common Stock with any excess at the option
    of the Holder to be forfeited or to be paid in cash by the Company to the Holder. For all purposes of this Warrant (other than Section
    1 and this Section 2), any reference herein to the “exercise” of this Warrant shall be deemed to include a reference
    to the exchange of this Warrant for Common Stock in accordance with the terms of this Section 2. For purposes of this Section 2,
    “Fair Market Value” shall mean the fair market value of one share of Common Stock as determined by the Board of
    Directors, in good faith.
	 	 	 
	 	b.	Automatic.
    To the extent not previously exercised in full pursuant to Section 1 or exchanged in full pursuant to Section 2(a), this Warrant
    shall, unless the Holder shall have previously notified the Company in writing of the Holder’s waiver of this Section 2(b),
    automatically be deemed to have been fully exchanged pursuant to the terms of Section 2(a) as of immediately before any expiration,
    termination or cancellation of this Warrant, if at such time the Fair Market Value per share of Common Stock (or other security issuable
    upon the exercise hereof) exceeds the per share Exercise Price, even if the Holder does not deliver an Exchange Notice or surrender
    this Warrant to the Company in connection therewith.

 

	3.	Issuance
    of Stock Certificates. As promptly as practicable after exercise or exchange and surrender of this Warrant and receipt of payment
    of the aggregate Exercise Price (if applicable), the Company shall issue and deliver to the Holder a certificate or certificates
    for the shares purchased hereunder in the name of the Holder.

 

    	2

     

    

 

	4.	Adjustment
    for Dividends, Distributions, Subdivisions, Combinations, Mergers, Consolidations or Sale of Assets.

 

	 	4.1.	Manner
    of Adjustment.
	 	 	 
	 	a.	Stock
    Dividends, Distributions or Subdivisions. In the event the Company shall issue shares of capital stock in a stock dividend, stock
    distribution or subdivision in respect of its Common Stock, the Exercise Price in effect immediately before such stock dividend,
    stock distribution or subdivision shall, concurrently with the effectiveness of such stock dividend, stock distribution or subdivision,
    be proportionately decreased and the number of Warrant Shares shall be proportionately increased.
	 	 	 
	 	b.	Combinations
    or Consolidations. In the event the outstanding shares of Common Stock shall be combined or consolidated, by reclassification
    or otherwise, into a lesser number of shares of Common Stock, the Exercise Price in effect immediately prior to such combination
    or consolidation shall, concurrently with the effectiveness of such combination or consolidation, be proportionately increased and
    the number of Warrant Shares shall be proportionately decreased.
	 	 	 
	 	c.	Adjustment
    for Reclassification, Exchange or Substitution. In the event that the class of securities issuable upon the exercise of this
    Warrant shall be changed into the same or a different number of shares of any class or classes of stock, whether by capital reorganization,
    reclassification or otherwise (other than any event addressed by Sections 4.1(a) or 4.1(b)), then and in each such event the Holder
    shall have the right thereafter to exercise this Warrant for the kind and amount of shares of stock and other securities and property
    receivable upon such reorganization, reclassification, or other change, by holders of the number of shares of the class of securities
    into which such Warrant might have been exercisable for immediately prior to such reorganization, reclassification, or change, all
    subject to further adjustment as provided herein.
	 	 	 
	 	d.	Adjustment
    for Merger, Consolidation or Sale of Assets. In the event that the Company shall merge or consolidate with or into another entity
    or sell all or substantially all of its assets (an “Acquisition”), this Warrant shall thereafter be exercisable
    for the kind and amount of shares of stock or other securities or property to which a holder of the Warrant Shares would have been
    entitled upon such Acquisition; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors)
    shall be made in the application of the provisions set forth in this Section 4 with respect to the rights and interest thereafter
    of the Holder of this Warrant, to the end that the provisions set forth in this Section 4 shall thereafter be applicable, as nearly
    as reasonably may be, in relation to any shares of stock or other property thereafter deliverable upon the exercise of this Warrant.
    Notwithstanding the foregoing sentence, a transaction shall not constitute an Acquisition if the primary purpose is to change the
    jurisdiction of the Company’s incorporation, create a holding company that will be owned in substantially the same proportions
    by the persons who held the Company’s securities immediately before such transaction, or engage in a bona fide equity financing
    transaction

 

    	3

     

    

 

	 	4.2.	Certificate
    as to Adjustments. Upon the occurrence of each adjustment or readjustment of the Exercise Price pursuant to this Section 4, the
    Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to
    the Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment
    or readjustment is based.
	 	 	 
	 	4.3.	Closing
    of Books. The Company shall at no time close its transfer books against the transfer of any of Warrant Shares in any manner which
    interferes with the timely and proper issuance of such shares.

 

	5.	Representations
    of Holder.

 

	 	5.1.	Acquisition
    of Warrant for Personal Account. The Holder represents and warrants that it is acquiring the Warrant and the Warrant Shares solely
    for its account for investment and not with a view to or for sale or distribution of said Warrant or Warrant Shares or any part thereof.
    The Holder also represents that the entire legal and beneficial interests of the Warrant and Warrant Shares the Holder is acquiring
    is being acquired for, and will be held for, its account only.
	 	 	 
	 	5.2.	Investment
    Experience; Accredited Investor. Holder understands that the purchase of this Warrant and its underlying securities involves
    substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that
    Holder can bear the economic risk of such Holder’s investment in this Warrant and its underlying securities and has such knowledge
    and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this
    Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of
    its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business
    acumen and financial circumstances of such persons. Holder is an “accredited investor” within the meaning of Regulation
    D promulgated under the Act.
	 	 	 
	 	5.3.	Securities
    Are Not Registered.
	 	 	 
	 	a.	The
    Holder understands that the Warrant and the Warrant Shares have not been registered under the Act on the basis that no distribution
    or public offering of the stock of the Company is to be effected. The Holder realizes that the basis for the exemption may not be
    present if, notwithstanding its representations, the Holder has a present intention of acquiring the securities for a fixed or determinable
    period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing
    the securities. The Holder has no such present intention.

 

    	4

     

    

 

	 	b.	The
    Holder recognizes that the Warrant and the Warrant Shares must be held indefinitely unless they are subsequently registered under
    the Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to register
    the Warrant or the Warrant Shares of the Company, or to comply with any exemption from such registration.
	 	 	 
	 	c.	The
    Holder is aware that neither the Warrant nor the Warrant Shares may be sold pursuant to Rule 144 adopted under the Act unless certain
    conditions are met, including, among other things, the existence of a public market for the shares, the availability of certain current
    public information about the Company, the resale following the required holding period under Rule 144 and the number of shares being
    sold during any three month period not exceeding specified limitations. Holder is aware that the conditions for resale set forth
    in Rule 144 have not been satisfied and that the Company presently has no plans to satisfy these conditions in the foreseeable future.

 

	6.	Notice
    of Certain Transactions. If (i) the Company effects an Acquisition or (ii) the Company completes its first underwritten public
    offering of its Common Stock under the Act (each event identified in clauses (i) and (ii) referred herein to as a “Transaction”),
    in any case while this Warrant remains outstanding, the Company shall give the Holder written notice of such Transaction at least
    20 days prior to the effective date of such Transaction. If an exercise or exchange of this Warrant is made in connection with any
    Transaction, such exercise or exchange may, at the Holder’s election, be conditioned upon the consummation of such Transaction,
    in which case such exercise or exchange shall not be deemed to be effective until immediately prior to the consummation of such Transaction.
	 	 
	7.	Covenants
    of the Company. During the period within which the rights represented by this Warrant may be exercised, the Company shall at
    all times have authorized and reserved for the purpose of issue upon exercise of the rights evidenced hereby, a sufficient number
    of shares of the class of securities issuable upon exercise of this Warrant to provide for the exercise of such rights. All securities
    which may be issued upon the exercise of the rights represented by this Warrant shall, upon issuance, be duly authorized, validly
    issued, fully paid and non-assessable and free from all taxes, liens and charges with respect to the issue thereof. Upon surrender
    for exercise, this Warrant shall be canceled and shall not be reissued; provided, however, that upon the partial exercise
    hereof a substitute Warrant of like tenor and date representing the rights to subscribe for and purchase any such unexercised portion
    hereof shall be issued.
	 	 
	8.	Voting
    Rights. This Warrant shall not entitle the Holder to any voting rights or any other rights as a stockholder of the Company but
    upon presentation of this Warrant with the Subscription Form or Exchange Notice duly executed and the tender of payment of the aggregate
    Exercise Price (if applicable) at the office of the Company pursuant to the provisions of this Warrant, the Holder shall forthwith
    be deemed a stockholder of the Company in respect of the securities for which the Holder has so subscribed and paid or exchanged.

 

    	5

     

    

 

	9.	No
    Change Necessary. The form of this Warrant need not be changed because of any adjustment in the Exercise Price or in the number
    of Warrant Shares. A Warrant issued after any adjustment or any partial exercise or upon replacement may continue to express the
    same Exercise Price and the same number of Warrant Shares (appropriately reduced in the case of partial exercise) as are stated on
    this Warrant as initially issued, and that Exercise Price and that number of Warrant Shares shall be considered to have been so changed
    as of the close of business on the date of adjustment.
	 	 
	10.	Notices
    to Holder. If at any time prior to the expiration of this Warrant and prior to its exercise, any of the following events shall
    occur:

 

	 	a.	The
    Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend or distribution
    payable otherwise than out of current or retained earnings, as indicated by the accounting treatment of such dividend or distribution
    on the books of the Company; or
	 	 	 
	 	b.	The
    consummation of a Transaction; then, in any one or more of said events, the Company shall give to the Holder written notice of such
    event. Such notice shall set forth the date on which such event shall take place, shall if applicable specify the deadline date as
    of which the holders of Common Stock of record shall be entitled or required to take any action, or the record date with respect
    to any dividend, and shall be given at least twenty (20) days prior to the deadline or record date. Failure to give such notice or
    any defect therein shall not affect the validity of any action taken in connection with the declaration or payment of any such dividend
    or the making of any such distribution or any action in connection with any such proposed Transaction.

 

	11.	Addresses
    for Notices. All notices, requests, consents and other communications hereunder shall be in writing, either delivered in hand
    or mailed by registered or certified mail, return receipt requested, or sent by facsimile, and shall be deemed to have been duly
    made when delivered:

 

	 	a.	If
    to the Holder, to the Holder’s address as shown on the books of the Company; or
	 	 	 
	 	b.	If
    to the Company, to Sanara MedTech Inc., Attn: Corporate Secretary at the Company’s principal executive office.

 

	12.	Substitution.
    In the case this Warrant shall be mutilated, lost, stolen or destroyed, the Company shall issue a new Warrant of like tenor and denomination
    and deliver the same (a) in exchange and substitution for and upon surrender and cancellation of any mutilated Warrant, or (b) in
    lieu of any Warrant lost, stolen or destroyed, upon receipt of evidence satisfactory to the Company of the loss, theft, or destruction
    of such Warrant (including, without limitation, a reasonably detailed affidavit with respect to the circumstances of any loss, theft
    or destruction), and of indemnity (or, in the case of the initial Holder or any other institutional holder, an indemnity agreement)
    satisfactory to the Company.

 

    	6

     

    

 

	13.	Transfer
    Restrictions. This Warrant shall be exercisable only by the Holder. Without the prior written consent of the Company, this Warrant
    shall not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be
    subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition
    of this Warrant or of any rights granted hereunder contrary to the provisions of this Section 13, or the levy of any attachment or
    similar process upon this Warrant or such rights, shall be null and void. Notwithstanding the foregoing, the Holder may transfer
    this Warrant in full to an affiliate or to a successor entity of the Holder or acquirer of the Holder in the event of a merger or
    consolidation or sale of substantially all of the assets of the Holder, provided that (1) the transferee shall be in writing bound
    by and subject to all the obligations and entitled to all the benefits of this Warrant as the “Holder” hereunder and
    (2) the Company obtains prior assurances reasonably satisfactory to the Company that such transfer is exempt from the registration
    requirements of, or is covered by an effective registration statement under, the Act and applicable state securities or “blue
    sky” laws, including, without limitation, receipt of an opinion to such effect of counsel reasonably satisfactory to the Company.
    The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder in connection with this
    Warrant may bear the following legend:

 

“THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES
LAWS OF APPLICABLE STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR
RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION UNDER SUCH LAWS OR AN
EXEMPTION FROM SUCH REGISTRATION REQUIREMENT. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF
THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS.”

 

	14.	Taxes.
    The Company makes no representation about tax treatment to the Holder with respect to receipt or exercise of this Warrant or acquiring,
    holding or disposing of the Warrant Shares, and the Holder represents that the Holder has had the opportunity to discuss such treatment
    with the Holder’s tax advisers.
	 	 
	15.	Remedies.
    Each party stipulates that the remedies at law in the event of any default or threatened default by the other party in the performance
    or compliance with any of the terms of this Warrant are and shall not be adequate, and that such terms may be specifically enforced
    by a decree for that specific performance of any agreement contained herein or by an injunction against a violation of any of the
    terms hereof or otherwise.
	 	 
	16.	Governing
    Law. This Warrant and any controversy arising out of or relating to this Warrant shall be governed by and construed in accordance
    with the internal laws of the State of Texas.
	 	 
	17.	Miscellaneous.
    This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the
    party against which enforcement of such change, waiver, discharge or termination is sought. The invalidity or unenforceability of
    any provision hereof shall in no way affect the validity or enforceability of any other provision.

 

[remainder
of page intentionally left blank]

 

    	7

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed effective as of the Original Issue Date.

 

	 	SANARA
    MEDTECH INC.
	 	 	 
	 	By:	/s/
    Michael D. McNeil
	 	Name:	Michael
    D. McNeil
	 	Title:	Chief
    Financial Officer

 

	ATTEST:	 
	 	 
	Furneaux
    Capital Holdco, LLC (DBA BlueIO)	 
	 	 	 
	By:	/s/
    Dave Furneaux	 
	Name:	Dave
Furneaux	 
	Title:	Chief
Executive Officer	 

 

[SIGNATURE
PAGE TO COMMON STOCK WARRANT]

 

    	8

     

    

 

Exhibit
A

 

Subscription
Form

 

(To
be Executed by the Holder in Order to Exercise the Warrant)

 

To:

Date:

 

The
undersigned, pursuant to the provisions set forth in the attached Warrant hereby irrevocably elects to purchase _____ shares of the Common
Stock of the Company (the “Common Stock”) covered by such Warrant and herewith makes payment of $__, representing the
[full/partial] purchase price for such shares at the price per share provided for in such Warrant. Capitalized terms defined, but not
used, herein shall have the meanings ascribed to them in such Warrant.

 

The
undersigned hereby agrees to take such other action and execute and deliver such other documents as the Company may require, in connection
with the issue of shares of Common Stock to the undersigned as aforesaid, in order to comply with the provisions of such Warrant.

 

The
undersigned is aware that the shares of Common Stock issuable upon exercise hereof (the “Shares”) have not been registered
under the Act or any state securities laws. The undersigned understands that the reliance by the Company on exemptions under the Act
is predicated in part upon the truth and accuracy of the statements of the undersigned in this Subscription Form and such Warrant.

 

The
undersigned represents and warrants that (1) it has been furnished with all information which it deems necessary to evaluate the merits
and risks of the purchase of the Shares, (2) it has had the opportunity to ask questions concerning the Shares and the Company and all
questions posed have been answered by the Company to its satisfaction, (3) it has been given the opportunity to obtain any additional
information it deems necessary to verify the accuracy of any information obtained concerning the Shares and the Company, (4) it has such
knowledge and experience in financial and business matters that it is able to evaluate the merits and risks of purchasing the Shares
and to make an informed investment decision relating thereto, and (5) it is an “Accredited Investor” as defined in Rule 501(a)
of Regulation D under the Act.

 

The
undersigned hereby represents and warrants that it is purchasing the Shares for its own account and not with a view to the sale or distribution
of all or any part of the Shares.

 

The
undersigned understands that because the Shares have not been registered under the Act, it must continue to bear the economic risk of
the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal
and state securities laws or an exemption from such registration is available.

 

The
undersigned agrees that it shall in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there
is an effective registration statement under the Act and applicable state securities laws covering any such transaction involving the
Shares or (2) the Company receives an opinion of legal counsel to the undersigned (concurred in by legal counsel for the Company) stating
that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration.

 

    	 

     

    

 

The
undersigned consents to the placing of a legend on its certificate for the Shares stating that the Shares has not been registered and
setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company
and with any transfer agents against the Shares until the Shares may be legally resold or distributed without restriction.

 

The
undersigned has considered the Federal and state income and other tax implications of the exercise of the Warrant and the purchase and
subsequent sale of the Shares.

 

	 	 
	 	Printed
    Name of Holder (Must conform in
	 	all
    respects to name of Holder as specified on the face of such Warrant)
	 	 
	 	 
	 	Signature
	 	 
	 	 
	 	Name
    of Signatory (for an entity only)
	 	 
	 	 
	 	Title
    of Signatory (for an entity only)

 

    	 

     

    

 

Exhibit
B

 

Exchange
Notice

 

(To
be Executed by the Holder in Order to Exchange the Warrant)

 

To:

Date:

 

The
undersigned, pursuant to the provisions set forth in the attached Warrant hereby irrevocably elects to exchange such Warrant with respect
to shares of the Common Stock of the Company (the “Common Stock”) covered by such Warrant which such Holder would be entitled
to receive upon the exercise thereof. Capitalized terms defined, but not used, herein shall have the meanings ascribed to them in such
Warrant.

 

The
undersigned hereby agrees to take such other action and execute and deliver such other documents as the Company may require, in connection
with the issue of shares of Common Stock to the undersigned as aforesaid, in order to comply with the provisions of such Warrant.

 

The
undersigned is aware that the shares of Common Stock issuable upon exercise hereof (the “Shares”) have not been registered
under the Act or any state securities laws. The undersigned understands that the reliance by the Company on exemptions under the Act
is predicated in part upon the truth and accuracy of the statements of the undersigned in this Subscription Form and such Warrant.

 

The
undersigned represents and warrants that (1) it has been furnished with all information which it deems necessary to evaluate the merits
and risks of the receipt of the Shares, (2) it has had the opportunity to ask questions concerning the Shares and the Company and all
questions posed have been answered by the Company to its satisfaction, (3) it has been given the opportunity to obtain any additional
information it deems necessary to verify the accuracy of any information obtained concerning the Shares and the Company, (4) it has such
knowledge and experience in financial and business matters that it is able to evaluate the merits and risks of receiving the Shares and
to make an informed investment decision relating thereto, and (5) it is an “Accredited Investor” as defined in Rule 501(a)
of Regulation D under the Act.

 

The
undersigned hereby represents and warrants that it is receiving the Shares for its own account and not with a view to the sale or distribution
of all or any part of the Shares.

 

The
undersigned understands that because the Shares have not been registered under the Act, it must continue to bear the economic risk of
the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal
and state securities laws or an exemption from such registration is available.

 

The
undersigned agrees that it shall in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there
is an effective registration statement under the Act and applicable state securities laws covering any such transaction involving the
Shares or (2) the Company receives an opinion of legal counsel to the undersigned (concurred in by legal counsel for the Company) stating
that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration.

 

    	 

     

    

 

The
undersigned consents to the placing of a legend on its certificate for the Shares stating that the Shares have not been registered and
setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company
and with any transfer agents against the Shares until the Shares may be legally resold or distributed without restriction.

 

The
undersigned has considered the Federal and state income and other tax implications of the exchange of the Warrant and the receipt and
subsequent sale of the Shares.

 

	 	 
	 	Printed
    Name of Holder (Must conform in
	 	all
    respects to name of Holder as specified on the face of such Warrant)
	 	 
	 	 
	 	Signature
	 	 
	 	 
	 	Name
    of Signatory (for an entity only)
	 	 
	 	 
	 	Title
    of Signatory (for an entity only)Exhibit
10.3

 

PRECISION
HEALING INC.

 

2020
STOCK OPTION AND GRANT PLAN

 

SECTION
1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS

 

The
name of the Plan is the Precision Healing Inc. 2020 Stock Option and Grant Plan (the “Plan”). The purpose of the Plan
is to encourage and enable the officers, employees, directors, Consultants and other key Persons of Precision Healing Inc., a Delaware
corporation (including any successor entity, the “Company”) and its Subsidiaries, upon whose judgment, initiative
and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.

 

The
following terms shall be defined as set forth below:

 

“Affiliate”
of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under
common control with the first mentioned Person. A Person shall be deemed to control another Person if such first Person possesses directly
or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the ownership
of voting securities, by contract or otherwise.

 

“Award”
or “Awards,” except where referring to a particular category of grant under the Plan, shall include Incentive Stock
Options, Non-Qualified Stock Options, early exercise Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards,
Restricted Stock Units or any combination of the foregoing.

 

“Award
Agreement” means a written or electronic agreement setting forth the terms and provisions applicable to an Award granted under
the Plan. Each Award Agreement may contain terms and conditions in addition to those set forth in the Plan; provided, however,
in the event of any conflict in the terms of the Plan and the Award Agreement, the terms of the Plan shall govern.

 

“Board”
means the Board of Directors of the Company.

 

“Cause”
shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not contain a definition of
“Cause,” it shall mean (i) the grantee’s dishonest statements or acts with respect to the Company or any Affiliate
of the Company, or any current or prospective customers, suppliers vendors or other third parties with which such entity does business;
(ii) the grantee’s commission of (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii)
the grantee’s failure to perform his assigned duties and responsibilities to the reasonable satisfaction of the Company which failure
continues, in the reasonable judgment of the Company, after written notice given to the grantee by the Company; (iv) the grantee’s
gross negligence, willful misconduct or insubordination with respect to the Company or any Affiliate of the Company; or (v) the grantee’s
material violation of any provision of any agreement(s) between the grantee and the Company relating to noncompetition, nonsolicitation,
nondisclosure and/or assignment of inventions.

 

    	 

    	 

    

 

“Code”
means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.

 

“Committee”
means the Committee of the Board referred to in Section 2.

 

“Consultant”
means any natural person that provides bona fide services to the Company (including a Subsidiary), and such services are not in connection
with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market
for the Company’s securities.

 

“Disability”
means “disability” as defined in Section 422(c) of the Code.

 

“Effective
Date” means the date on which the Plan is adopted as set forth on the final page of the Plan.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

 

“Fair
Market Value” of the Stock on any given date means the fair market value of the Stock determined in good faith by the Committee
based on the reasonable application of a reasonable valuation method not inconsistent with Section 409A of the Code. If the Stock is
admitted to trade on a national securities exchange, the determination shall be made by reference to the closing price reported on such
exchange. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date
for which there is a closing price. If the date for which Fair Market Value is determined is the first day when trading prices for the
Stock are reported on a national securities exchange, the Fair Market Value shall be the “Price to the Public” (or equivalent)
set forth on the cover page for the final prospectus relating to the Company’s Initial Public Offering.

 

“Good
Reason” shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not
contain a definition of “Good Reason,” it shall mean (i) a material
diminution in the grantee’s base salary except for across-the-board salary reductions similarly affecting all or substantially
all similarly situated employees of the Company or (ii) a change of more than fifty (50) miles in the geographic location at which
the grantee provides services to the Company, so long as the grantee provides at least ninety (90) days’ notice to the Company
following the initial occurrence of any such event and the Company fails to cure such event within thirty (30) days
thereafter.

 

“Grant
Date” means the date that the Committee designates in its approval of an Award in accordance with applicable law as the date
on which the Award is granted, which date may not precede the date of such Committee approval.

 

“Holder”
means, with respect to an Award or any Shares, the Person holding such Award or Shares, including the initial recipient of the Award
or any Permitted Transferee.

 

    	2

    	 

    

 

“Incentive
Stock Option” means any Stock Option designated and qualified as an “incentive stock option” as defined in Section
422 of the Code.

 

“Initial
Public Offering” means the consummation of the first firm commitment underwritten public offering pursuant to an effective
registration statement under the Securities Act covering the offer and sale by the Company of its equity securities, as a result of or
following which the Stock shall be publicly held.

 

“Non-Qualified
Stock Option” means any Stock Option that is not an Incentive Stock Option.

 

“Option”
or “Stock Option” means any option to purchase shares of Stock granted pursuant to Section 5.

 

“Optionee”
means the “Optionee” as it is defined in the Award Agreement for the applicable Incentive Stock Option or Non-Qualified Stock
Option.

 

“Permitted
Transferees” means any of the following to whom a Holder may transfer Shares hereunder (as set forth in Section 9(a)(ii)(A)):
the Holder’s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any Person sharing the
Holder’s household (other than a tenant or employee), a trust in which these Persons have more than fifty percent (50%) of the
beneficial interest, a foundation in which these Persons control the management of assets, and any other entity in which these Persons
own more than fifty percent (50%) of the voting interests; provided, however, that any such trust does not require or permit distribution
of any Shares during the term of the Award Agreement unless subject to its terms. Upon the death of the Holder, the term Permitted Transferees
shall also include such deceased Holder’s estate, executors, administrators, personal representatives, heirs, legatees and distributees,
as the case may be.

 

“Person”
means any individual, corporation, partnership (limited or general), limited liability company, limited liability partnership, association,
trust, joint venture, unincorporated organization or any similar entity.

 

“Restricted
Stock Award” means Awards granted pursuant to Section 6 and “Restricted Stock” means Shares issued pursuant
to such Awards.

 

“Restricted
Stock Unit” means an Award of phantom stock units to a grantee, which may be settled in cash or Shares as determined by the
Committee, pursuant to Section 8.

 

“Sale
Event” means the consummation of (i) the dissolution or liquidation of the Company, (ii) the sale of all or substantially all
of the assets of the Company on a consolidated basis to an unrelated Person or entity, (iii) a merger, reorganization or consolidation
pursuant to which the Holders of the Company’s outstanding voting power immediately prior to such transaction do not own a majority
of the outstanding voting power of the surviving or resulting entity (or its ultimate parent, if applicable), (iv) the acquisition of
all or a majority of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a Person
or group of Persons, or (v) any other acquisition of the business of the Company, as determined by the Board; provided, however,
that the Company’s Initial Public Offering, any subsequent public offering or another capital raising event, or a merger effected
solely to change the Company’s domicile shall not constitute a “Sale Event.”

 

    	3

    	 

    

 

“Section
409A” means Section 409A of the Code and the regulations and other guidance promulgated thereunder.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations thereunder.

 

“Service
Relationship” means any relationship as a full-time employee, part-time employee, director or other key Person (including Consultants)
of the Company or any Subsidiary or any successor entity (e.g., a Service Relationship shall be deemed to continue without interruption
in the event that an individual’s status changes from full-time employee to part-time employee or Consultant).

 

“Shares”
means shares of Stock.

 

“Stock”
means the Common Stock of the Company, $0.00001 par value per share.

 

“Subsidiary” means any corporation or other
entity (other than the Company) in which the Company owns more than a fifty percent (50%) of the combined voting power of all
classes of stock thereof, either directly or indirectly.

 

“Ten
Percent Owner” means an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the
Code) more than ten percent (10%) of the combined voting power of all classes of stock of the Company or any parent of the Company or
any Subsidiary.

 

“Termination
Event” means the termination of the Award recipient’s Service Relationship with the Company and its Subsidiaries for
any reason whatsoever, regardless of the circumstances thereof, and including, without limitation, upon death, disability, retirement,
discharge or resignation for any reason, whether voluntarily or involuntarily. The following shall not constitute a Termination Event:
(i) a transfer to the service of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another
Subsidiary or (ii) an approved leave of absence for military service or sickness, or for any other purpose approved by the Committee,
if the individual’s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which
the leave of absence was granted or if the Committee otherwise so provides in writing.

 

“Unrestricted
Stock Award” means any Award granted pursuant to Section 7 and “Unrestricted Stock” means Shares issued
pursuant to such Awards.

 

	SECTION 2.	 ADMINISTRATION OF PLAN; COMMITTEE AUTHORITY TO SELECT
GRANTEES AND DETERMINE AWARDS

 

(a) Administration
of Plan. The Plan shall be administered by the Board, or at the discretion of the Board, by a committee of the Board, comprised of
not less than two (2) directors. All references herein to the “Committee” shall be deemed to refer to the group then
responsible for administration of the Plan at the relevant time (i.e., either the Board or a committee or committees of the Board, as
applicable).

 

    	4

    	 

    

 

 

(b) Powers
of Committee. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan, including the
power and authority:

 

 (i) to select the individuals to whom Awards may from time to time be granted;

 

(ii)
to determine the time or times of grant, and the amount, if any, of Incentive Stock Options, Non-Qualified Stock Options, Restricted
Stock Awards, Unrestricted Stock Awards, Restricted Stock Units, or any combination of the foregoing, granted to any one or more
grantees;

 

(iii) to
determine the number of Shares to be covered by any Award and, subject to the provisions of the Plan, the price, exercise price, conversion
ratio or other price relating thereto;

 

(iv) to
determine and, subject to Section 12, to modify from time to time the terms and conditions, including restrictions, not inconsistent
with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve
the form of Award Agreements;

 

(v)
to accelerate at any time the exercisability or vesting of all or any portion of any Award;

 

(vi)
to impose any limitations on Awards, including limitations on transfers, repurchase provisions and the like, and to exercise
repurchase rights or obligations;

 

(vii) subject
to Section 5(a)(ii) and any restrictions imposed by Section 409A, to extend at any time the period in which Stock Options may be exercised;
and

 

(viii) at
any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings
as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including Award Agreements); to make all
determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and
to otherwise supervise the administration of the Plan.

 

All
decisions and interpretations of the Committee shall be binding on all Persons, including the Company and all Holders.

 

(c) Award
Agreement. Awards under the Plan shall be evidenced by Award Agreements that set forth the terms, conditions and limitations for
each Award.

 

    	5

    	 

    

 

(d) Indemnification.
Neither the Board nor the Committee, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation,
construction or determination made in good faith in connection with the Plan, and the members of the Board and the Committee (and any
delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage
or expense (including, without limitation, reasonable attorneys’ fees) arising or resulting therefrom to the fullest extent permitted
by law and/or under the Company’s governing documents, including its certificate of incorporation or bylaws, or any directors’
and officers’ liability insurance coverage which may be in effect from time to time and/or any indemnification agreement between
such individual and the Company.

 

(e) Foreign
Award Recipients. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries
in which the Company and any Subsidiary operate or have employees or other individuals eligible for Awards, the Committee, in its sole
discretion, shall have the power and authority to: (i) determine which Subsidiaries, if any, shall be covered by the Plan; (ii) determine
which individuals, if any, outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of
any Award granted to individuals outside the United States to comply with applicable foreign laws; (iv) establish subplans and modify
exercise procedures and other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable
(and such subplans and/or modifications shall be attached to the Plan as appendices); provided, however, that no such subplans
and/or modifications shall increase the share limitation contained in Section 3(a) hereof; and (v) take any action, before or after an
Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory
exemptions or approvals.

 

	SECTION 3.	 STOCK ISSUABLE UNDER THE PLAN; MERGERS AND OTHER TRANSACTIONS;
SUBSTITUTION

 

(a) Stock
Issuable. The maximum number of Shares reserved and available for issuance under the Plan shall be 895,000 Shares, subject to adjustment
as provided in Section 3(b). For purposes of this limitation, the Shares underlying any Awards that are forfeited, canceled, reacquired
by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) and Shares
that are withheld upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding shall be added
back to the Shares available for issuance under the Plan. Subject to such overall limitations, Shares may be issued up to such maximum
number pursuant to any type or types of Award, and no more than 3,000,000 Shares may be issued pursuant to Incentive Stock Options. The
Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the Company.

 

    	6

    	 

    

 

(b) Changes
in Stock. Subject to Section 3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend,
stock split, reverse stock split or other similar change in the Company’s capital stock, the outstanding Shares are increased or
decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional Shares or new or
different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares or other securities,
in each case, without the receipt of consideration by the Company, or, if, as a result of any merger or consolidation, or sale of all
or substantially all of the assets of the Company, the outstanding Shares are converted into or exchanged for other securities of the
Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an appropriate and proportionate adjustment
in (i) the maximum number of Shares reserved for issuance under the Plan, (ii) the number and kind of Shares or other securities subject
to any then outstanding Awards under the Plan, (iii) the repurchase price, if any, per Share subject to each outstanding Award, and (iv)
the exercise price for each Share subject to any then outstanding Stock Options under the Plan, without changing the aggregate exercise
price (i.e., the exercise price multiplied by the number of Stock Options) as to which such Stock Options remain exercisable. The Committee
shall in any event make such adjustments as may be required by Section 25102(o) of the California Corporation Code and the rules and
regulations promulgated thereunder. The adjustment by the Committee shall be final, binding and conclusive. No fractional Shares shall
be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash payment in lieu of fractional
shares.

 

 (c) Sale Events.

 

 (i) Options.

 

(A) In
the case of and subject to the consummation of a Sale Event, the Plan and all outstanding Options issued hereunder shall terminate upon
the effective time of any such Sale Event unless assumed or continued by the successor entity, or new stock options or other awards of
the successor entity or parent thereof are substituted therefor, with an equitable or proportionate adjustment as to the number and kind
of shares and, if appropriate, the per share exercise prices, as such parties shall agree (after taking into account any acceleration
hereunder and/or pursuant to the terms of any Award Agreement).

 

(B) In
the event of the termination of the Plan and all outstanding Options issued hereunder pursuant to Section 3(c), each Holder of Options
shall be permitted, within a period of time prior to the consummation of the Sale Event as specified by the Committee, to exercise all
such Options which are then exercisable or will become exercisable as of the effective time of the Sale Event; provided, however,
that the exercise of Options not exercisable prior to the Sale Event shall be subject to the consummation of the Sale Event.

 

(C) Notwithstanding
anything to the contrary in Section 3(c)(i)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation,
to make or provide for a cash payment to the Holders of Options, without any consent of the Holders, in exchange for the cancellation
thereof, in an amount equal to the difference between (A) the value as determined by the Committee of the consideration payable per share
of Stock pursuant to the Sale Event (the “Sale Price”) times the number of Shares subject to outstanding Options being
cancelled (to the extent then vested and exercisable, including by reason of acceleration in connection with such Sale Event, at prices
not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding vested and exercisable Options.

 

    	7

    	 

    

 

 (ii) Restricted Stock and Restricted Stock Unit Awards.

 

(A) In
the case of and subject to the consummation of a Sale Event, all unvested Restricted Stock and unvested Restricted Stock Unit Awards
(other than those becoming vested as a result of the Sale Event) issued hereunder shall be forfeited immediately prior to the effective
time of any such Sale Event unless assumed or continued by the successor entity, or awards of the successor entity or parent thereof
are substituted therefor, with an equitable or proportionate adjustment as to the number and kind of shares subject to such awards as
such parties shall agree (after taking into account any acceleration hereunder and/or pursuant to the terms of any Award Agreement).

 

(B) In
the event of the forfeiture of Restricted Stock pursuant to Section 3(c)(ii)(A), such Restricted Stock shall be repurchased from the
Holder thereof at a price per share equal to the original per share purchase price paid by the Holder (subject to adjustment as provided
in Section 3(b)) for such Shares.

 

(C) Notwithstanding
anything to the contrary in Section 3(c)(ii)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation,
to make or provide for a cash payment to the Holders of Restricted Stock or Restricted Stock Unit Awards, without consent of the Holders,
in exchange for the cancellation thereof, in an amount equal to the Sale Price times the number of Shares subject to such Awards, to
be paid at the time of such Sale Event or upon the later vesting of such Awards.

 

SECTION
4. ELIGIBILITY

 

Grantees
under the Plan will be such full or part-time officers and other employees, directors, Consultants and key Persons of the Company and
any Subsidiary who are selected from time to time by the Committee in its sole discretion; provided, however, that Awards shall
be granted only to those individuals described in Rule 701(c) of the Securities Act.

 

SECTION
5. STOCK OPTIONS

 

Upon
the grant of a Stock Option, the Company and the grantee shall enter into an Award Agreement. The terms and conditions of each such Award
Agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and grantees.

 

Stock
Options granted under the Plan may be either Incentive Stock Options or Non- Qualified Stock Options. Incentive Stock Options may be
granted only to employees of the Company or any Subsidiary that is a “subsidiary corporation” within the meaning of Section
424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock
Option.

 

(a) Terms
of Stock Options. The Committee in its discretion may grant Stock Options to those individuals who meet the eligibility requirements
of Section 4. Stock Options shall be subject to the following terms and conditions and shall contain such additional terms and conditions,
not inconsistent with the terms of the Plan, as the Committee shall deem desirable.

 

    	8

    	 

    

 

(i) Exercise
Price. The exercise price per share for the Shares covered by a Stock Option shall be determined by the Committee at the time of
grant but shall not be less than one hundred percent (100%) of the Fair Market Value on the Grant Date. In the case of an Incentive Stock
Option that is granted to a Ten Percent Owner, the exercise price per share for the Shares covered by such Incentive Stock Option shall
not be less than one hundred ten percent (110%) of the Fair Market Value on the Grant Date.

 

(ii) Option
Term. The term of each Stock Option shall be fixed by the Committee, but no Stock Option shall be exercisable more than ten (10)
years from the Grant Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option
shall be no more than five (5) years from the Grant Date.

 

(iii) Exercisability;
Rights of a Stockholder. Stock Options shall become exercisable and/or vested at such time or times, whether or not in installments,
as shall be determined by the Committee at or after the Grant Date. The Award Agreement may permit a grantee to exercise all or a portion
of a Stock Option immediately at grant; provided that the Shares issued upon such exercise shall be subject to restrictions and
a vesting schedule identical to the vesting schedule of the related Stock Option, such Shares shall be deemed to be Restricted Stock
for purposes of the Plan, and the Optionee may be required to enter into an additional or new Award Agreement as a condition to exercise
of such Stock Option. An Optionee shall have the rights of a stockholder only as to Shares acquired upon the exercise of a Stock Option
and not as to unexercised Stock Options. An Optionee shall not be deemed to have acquired any Shares unless and until a Stock Option
shall have been exercised pursuant to the terms of the Award Agreement and this Plan and the Optionee’s name has been entered on
the books of the Company as a stockholder.

 

(iv) Method
of Exercise. Stock Options may be exercised by an Optionee in whole or in part, by the Optionee giving written or electronic notice
of exercise to the Company, specifying the number of Shares to be purchased. Payment of the purchase price may be made by one or more
of the following methods (or any combination thereof) to the extent provided in the Award Agreement:

 

(A) In
cash, by certified or bank check, by wire transfer of immediately available funds, or other instrument acceptable to the Committee;

 

(B) If
permitted by the Committee, by the Optionee delivering to the Company a promissory note, if the Board has expressly authorized the loan
of funds to the Optionee for the purpose of enabling or assisting the Optionee to effect the exercise of his or her Stock Option; provided
that at least so much of the exercise price as represents the par value of the Stock shall be paid in cash if required by state law;

 

(C) If
permitted by the Committee and the Initial Public Offering has occurred (or the Stock otherwise becomes publicly-traded), through the
delivery (or attestation to the ownership) of Shares that have been purchased by the Optionee on the open market or that are beneficially
owned by the Optionee and are not then subject to restrictions under any Company plan. To the extent required to avoid variable accounting
treatment under ASC 718 or other applicable accounting rules, such surrendered Shares if originally purchased from the Company shall
have been owned by the Optionee for at least six (6) months. Such surrendered Shares shall be valued at Fair Market Value on the exercise
date;

 

    	9

    	 

    

 

(D) If
permitted by the Committee and the Initial Public Offering has occurred (or the Stock otherwise becomes publicly-traded), by the Optionee
delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver
to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that in the event that the
Optionee chooses to pay the purchase price as so provided, the Optionee and the broker shall comply with such procedures and enter into
such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure; or

 

(E) If
permitted by the Committee, and only with respect to Stock Options that are not Incentive Stock Options, by a “net exercise”
arrangement pursuant to which the Company will reduce the number of Shares issuable upon exercise by the largest whole number of Shares
with a Fair Market Value that does not exceed the aggregate exercise price.

 

Payment
instruments will be received subject to collection. No certificates for Shares so purchased will be issued to the Optionee or, with
respect to uncertificated Stock, no transfer to the Optionee on the records of the Company will take place, until the Company has
completed all steps it has deemed necessary to satisfy legal requirements relating to the issuance and sale of the Shares, which
steps may include, without limitation, (i) receipt of a representation from the Optionee at the time of exercise of the Option that
the Optionee is purchasing the Shares for the Optionee’s own account and not with a view to any sale or distribution of the
Shares or other representations relating to compliance with applicable law governing the issuance of securities, (ii) the legending
of the certificate (or notation on any book entry) representing the Shares to evidence the foregoing restrictions, and (iii)
obtaining from Optionee payment or provision for all withholding taxes due as a result of the exercise of the Option. The delivery
of certificates representing the shares of Stock (or the transfer to the Optionee on the records of the Company with respect to
uncertificated Stock) to be purchased pursuant to the exercise of a Stock Option will be contingent upon (A) receipt from the
Optionee (or a purchaser acting in his or her stead in accordance with the provisions of the Stock Option) by the Company of the
full purchase price for such Shares and the fulfillment of any other requirements contained in the Award Agreement or applicable
provisions of laws and (B) if required by the Company, the Optionee shall have entered into any stockholders agreements or other
agreements with the Company and/or certain other of the Company’s stockholders relating to the Stock. In the event that an
Optionee chooses to pay the purchase price by previously-owned Shares through the attestation method, the number of Shares
transferred to the Optionee upon the exercise of the Stock Option shall be net of the number of Shares attested to.

 

(b) Annual
Limit on Incentive Stock Options. To the extent required for “incentive stock option” treatment under Section 422 of
the Code, the aggregate Fair Market Value (determined as of the Grant Date) of the Shares with respect to which Incentive Stock Options
granted under the Plan and any other plan of the Company or its parent and any Subsidiary that become exercisable for the first time
by an Optionee during any calendar year shall not exceed $100,000 or such other limit as may be in effect from time to time under Section
422 of the Code. To the extent that any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.

 

    	10

    	 

    

 

(c) Termination.
Any portion of a Stock Option that is not vested and exercisable on the date of termination of an Optionee’s Service Relationship
shall immediately expire and be null and void. Once any portion of the Stock Option becomes vested and exercisable, the Optionee’s
right to exercise such portion of the Stock Option (or the Optionee’s representatives and legatees as applicable) in the event
of a termination of the Optionee’s Service Relationship shall continue until the earliest of: (i) the date which is: (A) twelve
(12) months following the date on which the Optionee’s Service Relationship terminates due to death or Disability (or such longer
period of time as determined by the Committee and set forth in the applicable Award Agreement), or (B) three (3) months following the
date on which the Optionee’s Service Relationship terminates if the termination is due to any reason other than death or Disability
(or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement), or (ii) the Expiration
Date set forth in the Award Agreement; provided that notwithstanding the foregoing, an Award Agreement may provide that if the
Optionee’s Service Relationship is terminated for Cause, the Stock Option shall terminate immediately and be null and void upon
the date of the Optionee’s termination and shall not thereafter be exercisable.

 

SECTION
6. RESTRICTED STOCK AWARDS

 

(a) Nature
of Restricted Stock Awards. The Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined
by the Committee) to an eligible individual under Section 4 hereof a Restricted Stock Award under the Plan. The Committee shall determine
the restrictions and conditions applicable to each Restricted Stock Award at the time of grant. Conditions may be based on continuing
employment (or other Service Relationship), achievement of pre-established performance goals and objectives and/or such other criteria
as the Committee may determine. Upon the grant of a Restricted Stock Award, the Company and the grantee shall enter into an Award Agreement.
The terms and conditions of each such Award Agreement shall be determined by the Committee, and such terms and conditions may differ
among individual Awards and grantees.

 

(b) Rights
as a Stockholder. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee of Restricted
Stock shall be considered the record owner of and shall be entitled to vote the Restricted Stock if, and to the extent, such Shares are
entitled to voting rights, subject to such conditions contained in the Award Agreement. The grantee shall be entitled to receive all
dividends and any other distributions declared on the Shares; provided, however, that the Company is under no duty to declare
any such dividends or to make any such distribution. Unless the Committee shall otherwise determine, certificates evidencing the Restricted
Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided in subsection (d) below of this
Section, and the grantee shall be required, as a condition of the grant, to deliver to the Company a stock power endorsed in blank and
such other instruments of transfer as the Committee may prescribe.

 

    	11

    	 

    

 

(c) Restrictions.
Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided
herein or in the Award Agreement. Except as may otherwise be provided by the Committee either in the Award Agreement or, subject to Section
12 below, in writing after the Award Agreement is issued, if a grantee’s Service Relationship with the Company and any Subsidiary
terminates, the Company or its assigns shall have the right, as may be specified in the relevant instrument, to repurchase some or all
of the Shares subject to the Award at such purchase price as is set forth in the Award Agreement.

 

(d) Vesting
of Restricted Stock. The Committee at the time of grant shall specify in the Award Agreement the date or dates and/or the attainment
of pre-established performance goals, objectives and other conditions on which the substantial risk of forfeiture imposed shall lapse
and the Restricted Stock shall become vested, subject to such further rights of the Company or its assigns as may be specified in the
Award Agreement.

 

SECTION
7. UNRESTRICTED STOCK AWARDS

 

The
Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined by the Committee) to an eligible
Person under Section 4 hereof an Unrestricted Stock Award under the Plan. Unrestricted Stock Awards may be granted in respect of past
services or other valid consideration, or in lieu of cash compensation due to such grantee.

 

SECTION
8. RESTRICTED STOCK UNITS

 

(a) Nature
of Restricted Stock Units. The Committee may, in its sole discretion, grant to an eligible Person under Section 4 hereof Restricted
Stock Units under the Plan. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Unit at
the time of grant. Vesting conditions may be based on continuing employment (or other Service Relationship), achievement of pre-established
performance goals and objectives and/or other such criteria as the Committee may determine. Upon the grant of Restricted Stock Units,
the grantee and the Company shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined
by the Committee and may differ among individual Awards and grantees. On or promptly following the vesting date or dates applicable to
any Restricted Stock Unit, but in no event later than March 15 of the year following the year in which such vesting occurs, such Restricted
Stock Unit(s) shall be settled in the form of cash or shares of Stock, as specified in the Award Agreement. Restricted Stock Units may
not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of.

 

(b) Rights
as a Stockholder. A grantee shall have the rights of a stockholder only as to Shares, if any, acquired upon settlement of Restricted
Stock Units. A grantee shall not be deemed to have acquired any such Shares unless and until the Restricted Stock Units shall have been
settled in Shares pursuant to the terms of the Plan and the Award Agreement, the Company shall have issued and delivered a certificate
representing the Shares to the grantee (or transferred on the records of the Company with respect to uncertificated stock), and the grantee’s
name has been entered in the books of the Company as a stockholder.

 

(c) Termination.
Except as may otherwise be provided by the Committee either in the Award Agreement or in writing after the Award Agreement is issued,
a grantee’s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee’s cessation
of Service Relationship with the Company and any Subsidiary for any reason.

 

    	12

    	 

    

 

	SECTION 9.	 TRANSFER RESTRICTIONS; COMPANY RIGHT OF FIRST REFUSAL;
COMPANY REPURCHASE RIGHTS

 

 (a) Restrictions on Transfer.

 

(i) Non-Transferability
of Stock Options. Stock Options and, prior to exercise, the Shares issuable upon exercise of such Stock Option, shall not be transferable
by the Optionee otherwise than by will, or by the laws of descent and distribution, and all Stock Options shall be exercisable, during
the Optionee’s lifetime, only by the Optionee, or by the Optionee’s legal representative or guardian in the event of the
Optionee’s incapacity. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide in the Award Agreement
regarding a given Stock Option that the Optionee may transfer by gift, without consideration for the transfer, his or her Non-Qualified
Stock Options to his or her family members (as defined in Rule 701 of the Securities Act), to trusts for the benefit of such family members,
or to partnerships in which such family members are the only partners (to the extent such trusts or partnerships are considered “family
members” for purposes of Rule 701 of the Securities Act), provided that the transferee agrees in writing with the Company
to be bound by all of the terms and conditions of this Plan and the applicable Award Agreement, including the execution of a stock power
upon the issuance of Shares. Stock Options, and the Shares issuable upon exercise of such Stock Options, shall be restricted as to any
pledge, hypothecation, or other transfer, including any short position, any “put equivalent position” (as defined in the
Exchange Act) or any “call equivalent position” (as defined in the Exchange Act) prior to exercise.

 

(ii) Shares.
No Shares shall be sold, assigned, transferred, pledged, hypothecated, given away or in any other manner disposed of or encumbered,
whether voluntarily or by operation of law, unless (i) the transfer is in compliance with the terms of the applicable Award
Agreement, all applicable securities laws (including, without limitation, the Securities Act), and with the terms and conditions of
this Section 9, (ii) the transfer does not cause the Company to become subject to the reporting requirements of the Exchange Act,
and (iii) the transferee consents in writing to be bound by the provisions of the Plan and the Award Agreement, including this
Section 9. In connection with any proposed transfer, the Committee may require the transferor to provide at the transferor’s
own expense an opinion of counsel to the transferor, satisfactory to the Committee, that such transfer is in compliance with all
foreign, federal and state securities laws (including, without limitation, the Securities Act). Any attempted transfer of Shares not
in accordance with the terms and conditions of this Section 9 shall be null and void, and the Company shall not reflect on its
records any change in record ownership of any Shares as a result of any such transfer, shall otherwise refuse to recognize any such
transfer and shall not in any way give effect to any such transfer of Shares. The Company shall be entitled to seek protective
orders, injunctive relief and other remedies available at law or in equity including, without limitation, seeking specific
performance or the rescission of any transfer not made in strict compliance with the provisions of this Section 9. Subject to the
foregoing general provisions, and unless otherwise provided in the applicable Award Agreement, Shares may be transferred pursuant to
the following specific terms and conditions (provided that with respect to any transfer of Restricted Stock, all vesting and
forfeiture provisions shall continue to apply with respect to the original recipient):

 

(A) Transfers
to Permitted Transferees. The Holder may transfer any or all of the Shares to one or more Permitted Transferees; provided, however,
that following such transfer, such Shares shall continue to be subject to the terms of this Plan (including this Section 9) and such
Permitted Transferee(s) shall, as a condition to any such transfer, deliver a written acknowledgment to that effect to the Company and
shall deliver a stock power to the Company with respect to the Shares. Notwithstanding the foregoing, the Holder may not transfer any
of the Shares to a Person whom the Company reasonably determines is a direct competitor or a potential competitor of the Company or any
of its Subsidiaries.

 

    	13

    	 

    

 

 

(B) Transfers
Upon Death. Upon the death of the Holder, any Shares then held by the Holder at the time of such death and any Shares acquired after
the Holder’s death by the Holder’s legal representative shall be subject to the provisions of this Plan, and the Holder’s
estate, executors, administrators, personal representatives, heirs, legatees and distributees shall be obligated to convey such Shares
to the Company or its assigns under the terms contemplated by the Plan and the Award Agreement.

 

(b) Right
of First Refusal. In the event that a Holder desires at any time to sell or otherwise transfer all or any part of his or her Shares
(other than shares of Restricted Stock which by their terms are not transferrable), the Holder first shall give written notice to the
Company of the Holder’s intention to make such transfer. Such notice shall state the number of Shares that the Holder proposes
to sell (the “Offered Shares”), the price and the terms at which the proposed sale is to be made and the name and
address of the proposed transferee. At any time within thirty (30) days after the receipt of such notice by the Company, the Company
or its assigns may elect to purchase all or any portion of the Offered Shares at the price and on the terms offered by the proposed transferee
and specified in the notice. The Company or its assigns shall exercise this right by mailing or delivering written notice to the Holder
within the foregoing thirty-day (30) period. If the Company or its assigns elect to exercise its purchase rights under this Section 9(b),
the closing for such purchase shall, in any event, take place within forty-five (45) days after the receipt by the Company of the initial
notice from the Holder. In the event that the Company or its assigns do not elect to exercise such purchase right, or in the event that
the Company or its assigns do not pay the full purchase price within such forty-five-day (45) period, the Holder shall be required to
pay a transaction processing fee of $10,000 to the Company (unless waived by the Committee) and then may, within sixty (60) days thereafter,
sell the Offered Shares to the proposed transferee and at the same price and on the same terms as specified in the Holder’s notice.
Any Shares not sold to the proposed transferee shall remain subject to the Plan. If the Holder is a party to any stockholders agreements
or other agreements with the Company and/or certain other of the Company’s stockholders relating to the Shares, (i) the transferring
Holder shall comply with the requirements of such stockholders agreements or other agreements relating to any proposed transfer of the
Offered Shares, and (ii) any proposed transferee that purchases Offered Shares shall enter into such stockholders agreements or other
agreements with the Company and/or certain of the Company’s stockholders relating to the Offered Shares on the same terms and in
the same capacity as the transferring Holder.

 

    	14

    	 

    

 

(c) Company’s Right of Repurchase.

 

(i) Right
of Repurchase for Unvested Shares Issued Upon the Exercise of an Option. Upon a Termination Event, the Company or its assigns shall
have the right and option to repurchase from a Holder of Shares acquired upon exercise of a Stock Option which are still subject to a
risk of forfeiture as of the Termination Event. Such repurchase rights may be exercised by the Company within the later of (A) six (6)
months following the date of such Termination Event or (B) seven (7) months after the acquisition of Shares upon exercise of a Stock
Option. The repurchase price shall be equal to the lower of the original per share price paid by the Holder, subject to adjustment as
provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its
repurchase rights.

 

(ii) Right
of Repurchase With Respect to Restricted Stock. Upon a Termination Event, the Company or its assigns shall have the right and option
to repurchase from a Holder of Shares received pursuant to a Restricted Stock Award any Shares that are still subject to a risk of forfeiture
as of the Termination Event. Such repurchase right may be exercised by the Company within six (6) months following the date of such Termination
Event. The repurchase price shall be the lower of the original per share purchase price paid by the Holder, subject to adjustment as
provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its
repurchase rights.

 

(iii) Procedure.
Any repurchase right of the Company shall be exercised by the Company or its assigns by giving the Holder written notice on or before
the last day of the repurchase period of its intention to exercise such repurchase right. Upon such notification, the Holder shall promptly
surrender to the Company, free and clear of any liens or encumbrances, any certificates representing the Shares being purchased, together
with a duly executed stock power for the transfer of such Shares to the Company or the Company’s assignee or assignees. Upon the
Company’s or its assignee’s receipt of the certificates from the Holder, the Company or its assignee or assignees shall deliver
to him, her or them a check for the applicable repurchase price; provided, however, that the Company may pay the repurchase price
by offsetting and canceling any indebtedness then owed by the Holder to the Company.

 

(d)
Drag Along Right. In the event the holders of a majority of the Company’s equity securities then outstanding (the “Majority
Shareholders”) determine to enter into a Sale Event in a bona fide negotiated transaction (a “Sale”), with
any non-Affiliate of the Company or any majority shareholder (in each case, the “Buyer”), a Holder of Shares, including
any Permitted Transferee, shall be obligated to and shall upon the written request of the Majority Shareholders: (a)sell, transfer
and deliver, or cause to be sold, transferred and delivered, to the Buyer, his or her Shares (including for this purpose all of such
Holder’s Shares that presently or as a result of any such transaction may be acquired upon the exercise of an Option (following
the payment of the exercise price therefor)) on substantially the same terms applicable to the Majority Shareholders (with appropriate
adjustments to reflect the conversion of convertible securities, the redemption of redeemable securities and the exercise of exercisable
securities as well as the relative preferences and priorities of preferred stock); and (b) execute and deliver such instruments of conveyance
and transfer and take such other action, including voting such Shares in favor of any Sale proposed by the Majority Shareholders and
executing any purchase agreements, merger agreements, indemnity agreements, escrow agreements or related documents as the Majority Shareholders
or the Buyer may reasonably require in order to carry out the terms and provisions of this Section 9(d).

 

    	15

    	 

    

 

 (e) Escrow Arrangement.

 

(i) Escrow.
In order to carry out the provisions of this Section 9 of this Plan more effectively, the Company shall hold any Shares issued pursuant
to Awards granted under the Plan in escrow together with separate stock powers executed by the Holder in blank for transfer. The Company
shall not dispose of the Shares except as otherwise provided in this Plan. In the event of any repurchase by the Company (or any of its
assigns), the Company is hereby authorized by the Holder, as the Holder’s attorney-in-fact, to date and complete the stock powers
necessary for the transfer of the Shares being purchased and to transfer such Shares in accordance with the terms hereof. At such time
as any Shares are no longer subject to the Company’s repurchase and first refusal rights, the Company shall, at the written request
of the Holder, deliver to the Holder a certificate representing such Shares with the balance of the Shares to be held in escrow pursuant
to this Section.

 

(ii) Remedy.
Without limitation of any other provision of this Plan or other rights, in the event that a Holder or any other Person is required to
sell a Holder’s Shares pursuant to the provisions of Sections 9(b) or (c) hereof and in the further event that he or she refuses
or for any reason fails to deliver to the Company or its designated purchaser of such Shares the certificate or certificates evidencing
such Shares together with a related stock power, the Company or such designated purchaser may deposit the applicable purchase price for
such Shares with a bank designated by the Company, or with the Company’s independent public accounting firm, as agent or trustee,
or in escrow, for such Holder or other Person, to be held by such bank or accounting firm for the benefit of and for delivery to him,
her, them or it, and/or, in its discretion, pay such purchase price by offsetting any indebtedness then owed by such Holder as provided
above. Upon any such deposit and/or offset by the Company or its designated purchaser of such amount and upon notice to the Person who
was required to sell the Shares to be sold pursuant to the provisions of Sections 9(b) or (c), such Shares shall at such time be deemed
to have been sold, assigned, transferred and conveyed to such purchaser, such Holder shall have no further rights thereto (other than
the right to withdraw the payment thereof held in escrow, if applicable), and the Company shall record such transfer in its stock transfer
book or in any appropriate manner.

 

(f) Lockup
Provision. If requested by the Company, a Holder shall not sell or otherwise transfer or dispose of any Shares (including, without
limitation, pursuant to Rule 144 under the Securities Act) held by him or her for such period following the effective date of a public
offering by the Company of Shares as the Company shall specify reasonably and in good faith. If requested by the underwriter engaged
by the Company, each Holder shall execute a separate letter confirming his or her agreement to comply with this Section.

 

(g) Adjustments
for Changes in Capital Structure. If, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock
split, reverse stock split or other similar change in the Stock, the outstanding Shares are increased or decreased or are exchanged for
a different number or kind of securities of the Company, the restrictions contained in this Section 9 shall apply with equal force to
additional and/or substitute securities, if any, received by Holder in exchange for, or by virtue of his or her ownership of, Shares.

 

    	16

    	 

    

 

(h) Termination.
The terms and provisions of Section 9(b) and Section 9(c) (except for the Company’s right to repurchase Shares still subject to
a risk of forfeiture upon a Termination Event) shall terminate upon the closing of the Company’s Initial Public Offering or upon
consummation of any Sale Event, in either case as a result of which Shares are registered under Section 12 of the Exchange Act and publicly-traded
on any national security exchange.

 

SECTION
10. TAX WITHHOLDING

 

(a) Payment
by Grantee. Each grantee shall, no later than the date as of which the value of an Award or of any Shares or other amounts received
thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements
satisfactory to the Committee regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by
the Company with respect to such income. The Company and any Subsidiary shall, to the extent permitted by law, have the right to deduct
any such taxes from any payment of any kind otherwise due to the grantee. The Company’s obligation to deliver stock certificates
(or evidence of book entry) to any grantee is subject to and conditioned on any such tax withholding obligations being satisfied by the
grantee.

 

(b) Payment
in Stock. The Company’s minimum required tax withholding obligation may be satisfied, in whole or in part, by the Company withholding
from Shares to be issued pursuant to an Award a number of Shares having an aggregate Fair Market Value (as of the date the withholding
is effected) that would satisfy the minimum withholding amount due.

 

SECTION
11. SECTION 409A AWARDS

 

To
the extent that any Award is determined to constitute “nonqualified deferred compensation” within the meaning of Section
409A (a “409A Award”), the Award shall be subject to such additional rules and requirements as may be specified by
the Committee from time to time. In this regard, if any amount under a 409A Award is payable upon a “separation from service”
(within the meaning of Section 409A) to a grantee who is considered a “specified employee” (within the meaning of Section
409A), then no such payment shall be made prior to the date that is the earlier of (i) six (6) months and one (1) day after the grantee’s
separation from service, or (ii) the grantee’s death, but only to the extent such delay is necessary to prevent such payment from
being subject to interest, penalties and/or additional tax imposed pursuant to Section 409A. The Company makes no representation or warranty
and shall have no liability to any grantee under the Plan or any other Person with respect to any penalties or taxes under Section 409A
that are, or may be, imposed with respect to any Award.

 

    	17

    	 

    

 

SECTION
12. AMENDMENTS AND TERMINATION

 

The
Board may, at any time, amend or discontinue the Plan and the Committee may, at any time, amend or cancel any outstanding Award for the
purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding
Award without the consent of the Holder of the Award. The Committee may exercise its discretion to reduce the exercise price of outstanding
Stock Options or effect repricing through cancellation of outstanding Stock Options and by granting such Holders new Awards in replacement
of the cancelled Stock Options. To the extent determined by the Committee to be required either by the Code to ensure that Incentive
Stock Options granted under the Plan are qualified under Section 422 of the Code or otherwise, Plan amendments shall be subject to approval
by the Company stockholders entitled to vote at a meeting of stockholders. Nothing in this Section 12 shall limit the Board’s or
Committee’s authority to take any action permitted pursuant to Section 3(c). The Board reserves the right to amend the Plan and/or
the terms of any outstanding Stock Options to the extent reasonably necessary to comply with the requirements of the exemption pursuant
to paragraph (f)(4) of Rule 12h-1 of the Exchange Act.

 

SECTION
13. STATUS OF PLAN

 

With
respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by
a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise
expressly so determine in connection with any Award.

 

SECTION
14. GENERAL PROVISIONS

 

(a) No
Distribution; Compliance with Legal Requirements. The Committee may require each Person acquiring Shares pursuant to an Award to
represent to and agree with the Company in writing that such Person is acquiring the Shares without a view to distribution thereof. No
Shares shall be issued pursuant to an Award until all applicable securities law and other legal and stock exchange or similar requirements
have been satisfied. The Committee may require the placing of such stop-orders and restrictive legends on certificates for Stock and
Awards as it deems appropriate.

 

(b) Delivery
of Stock Certificates. Stock certificates to grantees under the Plan shall be deemed delivered for all purposes when the Company
or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at
the grantee’s last known address on file with the Company; provided that stock certificates to be held in escrow pursuant
to Section 9 of the Plan shall be deemed delivered when the Company shall have recorded the issuance in its records. Uncertificated Stock
shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have given to the grantee
by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee’s last known address
on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic “book entry”
records).

 

(c) No
Employment Rights. The adoption of the Plan and the grant of Awards do not confer upon any Person any right to continued employment
or Service Relationship with the Company or any Subsidiary.

 

(d) Trading
Policy Restrictions. Option exercises and other Awards under the Plan shall be subject to the Company’s insider trading policy-related
restrictions, terms and conditions as may be established by the Committee, or in accordance with policies set by the Committee, from
time to time.

 

    	18

    	 

    

 

(e) Designation
of Beneficiary. Each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise
any Award on or after the grantee’s death or receive any payment under any Award payable on or after the grantee’s death.
Any such designation shall be on a form provided for that purpose by the Committee and shall not be effective until received by the Committee.
If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary
shall be the grantee’s estate.

 

(f) Legend.
Any certificate(s) representing the Shares shall carry substantially the following legend (and with respect to uncertificated Stock,
the book entries evidencing such Shares shall contain the following notation):

 

The
transferability of this certificate and the shares of stock represented hereby are subject to the restrictions, terms and conditions
(including repurchase and restrictions against transfers) contained in the Precision Healing Inc. 2020 Stock Option and Grant Plan and
any agreements entered into thereunder by and between the Company and the holder of this certificate (a copy of which is available at
the offices of the Company for examination).

 

(g) Information
to Holders of Options. In the event that the Company is relying on the exemption from the registration requirements of Section 12(g)
of the Exchange Act contained in paragraph (f)(1) of Rule 12h-1 of the Exchange Act, the Company shall provide the information described
in Rule 701(e)(3), (4) and (5) of the Securities Act to all Holders of Options in accordance with the requirements thereunder. The foregoing
notwithstanding, the Company shall not be required to provide such information unless the optionholder has agreed in writing, on a form
prescribed by the Company, to keep such information confidential.

 

SECTION
15. EFFECTIVE DATE OF PLAN

 

The
Plan shall become effective upon adoption by the Board and shall be approved by stockholders in accordance with applicable state law
and the Company’s articles of incorporation and bylaws within twelve (12) months thereafter. If the stockholders fail to approve
the Plan within twelve (12) months after its adoption by the Board, then any Awards granted or sold under the Plan shall be rescinded
and no additional grants or sales shall thereafter be made under the Plan. Subject to such approval by stockholders and to the requirement
that no Shares may be issued hereunder prior to such approval, Stock Options and other Awards may be granted hereunder on and after adoption
of the Plan by the Board. No grants of Stock Options and other Awards may be made hereunder after the tenth (10th) anniversary
of the date the Plan is adopted by the Board or the date the Plan is approved by the Company’s stockholders, whichever is earlier.

 

    	19

    	 

    

 

SECTION
16. GOVERNING LAW

 

This
Plan, all Awards and any controversy arising out of or relating to this Plan and all Awards shall be governed by and construed in accordance
with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be
governed by and construed in accordance with the internal laws of the State of Delaware, without regard to conflict of law principles
that would result in the application of any law other than the law of the State of Delaware.

 

DATE
ADOPTED BY THE BOARD:

 

DATE
APPROVED BY THE STOCKHOLDERS:

 

    	20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]